Studies on the pathogenesis of diabetes mellitus complications indicate that the compounds reducing free radicals and enhancing DNA repair could be prospective as possible remedies. Carbatonides, the disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives, were tested for these properties. EPR spectroscopy showed that metcarbatone was an effective scavenger of hydroxyl radicals produced in the Fenton reaction, etcarbatone, and propcarbatone were less effective, styrylcarbatone was ineffective. UV/VIS spectroscopy revealed that styrylcarbatone manifested a hyperchromic effect when interacting with DNA, while all other carbatonides showeda hypochromic effect. Rats with streptozotocin induced type 1 DM were treated with metcarbatone, etcarbatone or styrylcarbatone (all compounds at doses 0.05 mg kg -1 or 0.5 mg kg -1 ) nine days after the DM approval. Gene expression levels in kidneys and blood were evaluated by quantitative RT-PCR; protein expression -immunohistochemically in kidneys, heart, sciatic nerve, and eyes; DNA breakage -by comet assay in nucleated blood cells. Induction of DM induced DNA breaks; metcarbatone and styrylcarbatone (low dose) alleviated this effect. Metcarbatone and etcarbatone up-regulated mRNA and protein of eNOS in kidneys of diabetic animals; etcarbatone also in myocardium. Etcarbatone reduced the expression of increased iNOS protein in myocardium, nerve, and kidneys. iNos gene expression was up-regulated in kidneys by etcarbatone and metcarbatone in diabetic animals. In blood, development of DM increased iNos gene expression; etcarbatone and metcarbatone normalised it. Etcarbatone up-regulated the expression of H2AX in kidneys of diabetic animals but decreased the production of c-PARP1. Taken together, our data indicate that carbatonides might have a potential as drugs intended to treat DM complications.
, Riga, Latvia Studies on the pathogenesis of diabetes mellitus complications indicate that the compounds reducing free radicals and enhancing DNA repair could be prospective as possible remedies. Carbatonides, the disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives, were tested for these properties. EPR spectroscopy showed that metcarbatone was an effective scavenger of hydroxyl radicals produced in the Fenton reaction, etcarbatone, and propcarbatone were less effective, styrylcarbatone was ineffective. UV/VIS spectroscopy revealed that styrylcarbatone manifested a hyperchromic effect when interacting with DNA, while all other carbatonides showeda hypochromic effect. Rats with streptozotocin induced type 1 DM were treated with metcarbatone, etcarbatone or styrylcarbatone (all compounds at doses 0.05 mg kg -1 or 0.5 mg kg -1 ) nine days after the DM approval. Gene expression levels in kidneys and blood were evaluated by quantitative RT-PCR; protein expression -immunohistochemically in kidneys, heart, sciatic nerve, and eyes; DNA breakage -by comet assay in nucleated blood cells. Induction of DM induced DNA breaks; metcarbatone and styrylcarbatone (low dose) alleviated this effect. Metcarbatone and etcarbatone up-regulated mRNA and protein of eNOS in kidneys of diabetic animals; etcarbatone also in myocardium. Etcarbatone reduced the expression of increased iNOS protein in myocardium, nerve, and kidneys. iNos gene expression was up-regulated in kidneys by etcarbatone and metcarbatone in diabetic animals. In blood, development of DM increased iNos gene expression; etcarbatone and metcarbatone normalised it. Etcarbatone up-regulated the expression of H2AX in kidneys of diabetic animals but decreased the production of c-PARP1. Taken together, our data indicate that carbatonides might have a potential as drugs intended to treat DM complications. KEY WORDS: 1,4-dihydropyridine derivatives; diabetes mellitus; DNA damage; free radical scavengers; nitric oxide synthases New remedies for treatment of type one diabetes mellitus (T1DM) complications are sought among compounds with antioxidant activities (1, 2) . Following this logic, we have chosen some representatives of group of 1,4-dihydropyridine (1,4-DHP) derivatives synthesised in the Latvian Institute of Organic Synthesis (see Table 1 for structures). These compounds did not manifest high Ca 2+ -channel blocker activity (3), however, they displayed antioxidant activities (4) and interfered with mitochondria by uncoupling respiration and phosphorylation (5) . Some of these compounds manifested antidiabetic activities. For example, cerebrocrast promoted decrease of food intake (6) , protected pancreatic cells from streptozotocin (STZ)-induced damage and reduced glucose level in blood of animals with developed DM (7, 8) , and acted synergistically with insulin on heart functions and metabolism in diabetic rats (9) . The same 1,4-DHP derivative and its analogues normalised nitric oxide (NO) production in diabetic animals and modified expression of genes involved in NO metabolism (10) . Besides its antioxidant properties, 1,4-DHP derivative AV-153 turns out to be a DNA repair enhancer (11) capable of interacting directly with DNA (12); cerebrocrast and its analogues manifest identical properties (10) . We have shown that AV-153 down-regulates poly(ADP)ribose polymerase 1 (PARP1) and inducible NO synthase (iNOS) protein expression and increases the level of endothelial NO synthase (eNOS) protein and H2A histone family member X (H2afx) gene expression in kidneys of animals with experimental DM (13) . Several 1,4-DHPs modify expression of proteasomal genes (14) . Taken together, this group of 1,4-DHP derivatives appeared to be prospective for the study of their possible application as remedies against DM complications and should be studied further.
The aim of the present work was to test disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives (carbatonides) with different groups in position 4 by means of EPR spectroscopy for its capability to scavenge hydroxyl radical produced in the Fenton reaction, to protect DNA against above mentioned radicals in vitro, and to bind DNA. A series of in vivo experiments were conducted to study mRNA and protein expression levels in healthy animals and the expression of several proteins and genes involved in apoptosis, DNA repair, and free radical production in animals with STZ-induced diabetes mellitus. It is considered that impaired production of NO is a crucial point in development of DM complications. It is mainly due to the uncoupling of eNOS and overexpression of iNOS, as well as increased NO synthase-independent generation of NO by xanthine dehydrogenase (XDH) (10, 13 and references therein). This determined the choice of the abovementioned genes. Generation of DNA lesions and impaired DNA repair is also an important step in the pathogenesis of DM complications. The level of poly(ADP) ribose synthesis by PARPs characterises the intensity of the repair response to DNA lesions. This determined the choice of the PARP1 gene and protein study; moreover, the cleaved form of the protein is a sensitive apoptosis marker. H2AX histone, a sensitive marker of DNA double strand breaks, was chosen also to characterise the level of DNA lesions (13 and references therein).
MATERIALS AND METHODS

Chemicals
Carbatone, metcarbatone, etcarbatone, propcarbatone, and styrylcarbatone (J-9-125) ( 
at the Latvian Institute of Organic Synthesis and characterised by usual physico-chemical methods: 1 H-NMR, 13 C-NMR, IR spectroscopy, as well as LC-MS and elemental analysis. STZ, citric acid, EDTA, ferrous sulphate, hydrogen peroxide, low-melting agarose, NaCl, NaOH, Tris base, 5,5-dimethylpyrroline-N-oxide, ethidium bromide, and TRI reagent were purchased from SigmaAldrich Chemie (Taufkirchen, Germany).
In vitro experiments Fenton reaction -ESR measurements
Trapping of the hydroxyl radical was performed by 5,5-dimethylpyrroline-N-oxide (DMPO)-spin trap. EPR spectra of the spin trap and radical complex were recorded at room temperature using a Bruker D-200 ER spectrometer (IBM Bruker Ltd, Coventry, UK), operating at X-band with a TM cavity and capillary tube. and 20 μL of 1,4-DHP were mixed in a test tube to a final volume of 100 μL and the reaction mixture was then transferred to a capillary tube for the measurement of the EPR signal. The EPR spectrometer settings were as follows: modulation frequency -100 kHz; X band microwave frequency -9.5 GHz; microwave power 0-15 mW (milliwatts); modulation amplitude -1.0 G (gauss); time constant -160 s; scan time -200 s, and receiver gain -1 × l0 5 (15) .
UV/VIS spectroscopic measurements and fluorescence assays
UV-VIS spectra of the tested compounds were recorded on a Perkin Elmer Lambda 25 UV/VIS spectrophotometer in the absence of DNA and presence of increasing amounts of DNA in 5 mmol L -1 NaCl and 5 mmol L -1 Tris HCl at pH 7. The solution of the tested compound (25 μmol L -1 ) was diluted out of 1 mmol L -1 stock solution in the buffer in a quartz cell (1 mL). The reference cell was filled with 1 mL of buffer. The mixture was mixed thoroughly and titrated with 7.48 mmol L -1 of sonicated pTZ57R plasmid DNA solution, 5 μL each time to both sample and reference cells. Spectra were recorded in 400-200 nm interval at room temperature (10 
Experiment design
In total, 128 rats were used in the study. T1DM was induced by STZ injection via the tail vein (50 mg kg -1 , freshly dissolved in 10 mmol L -1 citrate buffer, pH 4.5, injection volume 0.2-0.25 mL). Control rats received 0.2 mL of 0.9 % NaCl via the tail vein. Diabetes was certified by measuring glucose level in tail vein blood of the fed rats in the morning 48 hours after the induction using a portative glucometer MediSense OptiumXceed (Abbott Diagnostics Ltd, Maidenhead, UK). Animals with blood glucose >13.89 mmol L -1 (250 mg dL -1 ) were used in experiments. The experiment was performed at day nine after confirmation of DM. Rats were divided in two big groups: control group (animals without DM) and STZ group (animals with induced DM). Each group was divided in seven subgroups: animals with no treatment, animals treated with either metcarbatone at low dose (0.05 mg kg -1 p.o. of metcarbatone for three days), metcarbatone at high dose (0.5 mg kg -1 , similarly), etcarabtone at low dose, etcarbatone at high dose, styrylcarbatone at low dose or styrylcarbatone at high dose. Each group contained at least three animals. After the treatment course glucose was measured, then the rats were euthanised, kidney and blood samples of all animals were taken and frozen in liquid nitrogen for RNA extraction. Samples of heart, kidneys, eyes and sciatic nerve of animals in groups of untreated animals and animals treated with metcarbatone and etcarbatone were fixed for immunochemistry.
Tissue processing and immunohistochemical examination
Rat kidney, heart, eye and sciatic nerve tissue specimens were processed and examined essentially as described (10) . Tissue specimens were fixed in 10 % neutral buffered formalin and embedded in paraffin. Specimens were cut in 5 µm thick section on a rotary microtome and mounted on poly-lysine coated glass slide. The following antibodies were used: rabbit polyclonal eNOS antibody (AbCam, Cambridge, UK, ab 66127; dilution 1:100), rabbit polyclonal iNOS antibody (AbCam, ab 3523; dilution 1:200), anti-cleaved PARP1 rabbit monoclonal antibody (AbCam, ab32651, dilution 1:200), and rabbit polyclonal histone gamma-H2AX antibody (AbCam, ab11175, dilution 1:500). Bound antibodies were detected using the EnVision (DAKO, Glostrup, Denmark) reagent (30 min at room temperature). The immunoperoxidase reaction colour was developed by incubating the slides with diaminobenzidine for 7 min. Each experiment included a negative control (mice tissues) omitting the primary antibody and positive controls (human tissues) -lung tissue and liver tissues for iNOS, liver and aorta tissues for eNOS and thyroid papillary carcinoma tissue for cleaved PARP1 and histone H2AX.
Gene expression studies
Gene expression studies were performed as described (10) . Total RNA was isolated from kidneys and blood using TRI reagent and purified using DNA-free kit (Ambion, Austin, TX, USA). RNA quantity and purity were determined by spectrophotometry. The integrity of RNAs was monitored by gel electrophoresis and only specimens with well-pronounced rRNA bands were taken for reactions. To obtain cDNA, 2 μg of RNA were reverse-transcribed using a random hexamer primer (RevertAid™ First Strand Synthesis Kit, Fermentas, Vilnius, Lithuania) (10). Primer s e q u e n c e s f o r i N o s g e n e w e r e 5'-GCTACACTTCCAACGCAACA-3' (forward primer) and 5'-CATGGTGAACACGTTCTTGG-3' (reverse p r i m e r ) . P r i m e r s f o r e N o s g e n e w e r e 5'-GAACCTGAGGGTGCCCAG-3' (forward primer) and 5'-TCCGATTCAACAGTGTCTCCT-3' (reverse primer). P r i m e r s f o r P a r p 1 g e n e w e r e 5'-CGGAGAGGCTTTACCGAGTG-3' (forward primer) and 5'-GAACATGGGTGACTGCACCA-3' (reverse p r i m e r ) . P r i m e r s f o r H 2 a f x g e n e w e r e 5'-CGGTTTGTCTCCTGGCGTTT-3' (forward primer) and 5'-ACATCGTGTGCGAGGTAGAA-3' (reverse primer). Primers for xanthine deoxygenase gene Xdh were 5'-CGGACCCTGAAACAACACTT-3' (forward primer) and 5'-CAAGCAGGCATTGACAGAAA-3' (reverse p r i m e r ) .
R N A -p o l y m e r a s e I I ( 5 ' -G C C A G A G T C T C C C AT G T G T T-3 ' a n d 5'-GTCGGTGGGACTCTGTTTGT-3', 135 bp) was chosen as a reference gene. SYBR ® Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) was used for determination of gene expression. Amplification and detection of specific products were performed on a StepOne™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) using the following temperature-time profile: one cycle of 95 ºC for 10 min, and 40 cycles of 95 ºC for 15 sec, 60 ºC for 1 min.
To check the specificity of the amplification products, the dissociation curve mode was used (one cycle at 95 ºC for 15 sec, 60 ºC for 1 min, and 95 ºC for 15 sec).
The single cell gel electrophoresis (comet assay)
The comet assay was performed as described (11, 16) with minor modifications (17) . Blood for the comet assay was taken from the tail vein into a plastic capillary with heparin (Microvette CB 300, Sarstedt, Germany). Next, 10 µL of fresh heparinised blood were mixed with 120 µL of prewarmed (37 ºC) 1 % low-melting agarose, 100 µL of the mixture were placed on a microscope slide that had been pre-coated with 0.5 % normal melting-point agarose. The cell membranes were lysed by keeping the slides in a cold lysing solution (pH 10.0) that contained 2.5 mol L -1 NaCl, 10 mmol L -1 Na 2 EDTA, 10 mmol L -1 Tris, 1 % Triton-X 100, 5 % DMSO (Sigma-Aldrich, Germany), for at least 1 h. Subsequently, the slides were placed in a horizontal tank filled with fresh electrophoresis buffer (1 mmol L -1 Na 2 EDTA, 300 mmol L -1 NaOH, pH 13.2) for 20 min to allow DNA to unwind. Then, horizontal electrophoresis was carried out for 20 min at 300 mA, 1 V cm -1 and 4 °C. After electrophoresis, slides were washed twice for 5 min with 0.4 mol L -1 Tris buffer (pH 7.5) for neutralisation and then fixed in ice-cold 96 % ethanol for 10 min. Slides were dried and stained with ethidium bromide and analysed with a fluorescence microscope equipped with 515-560 nm excitation filter and 590 nm barrier filter. Cells were visually graded into five classes (A 0 -A 4 ) (11) from class 0 (undamaged, no discernible tail) to class 4 (almost all DNA in tail, insignificant head). The mean value of DNA damage (D) in arbitrary units was calculated as follows:
Statistics
GraphPad Prism 6 software (San Diego, CA, USA) was used for statistical analysis. Results of the immunohistochemical data, real time PCR, and comet assay were analysed by an unpaired t test with Welch's correction and two-way ANOVA followed by Dunnett's multiple comparisons test. Data are presented as means±SEM.
RESULTS
Radical scavenging -EPR measurements
The ability of the 1,4-DHPs to scavenge the OH radical produced in the Fenton reaction was tested by the ESR method. The signals of the second compound of EPR spectra were measured on the 3 rd (I 3 ) and 5 th min (I 5 ) and the difference between them I 3 -I 5 was calculated ( Fig. 1; A) . The scavengers of OH radicals should increase the difference between I 3 and I 5. Representative kinetics of the decrease in the EPR signal intensity is shown in Figure 1B . Compounds were given at 1 mmol L -1 concentration.
Carbatone did not scavenge the hydroxyl radical produced in the Fenton reaction, metcarbatone was an effective scavenger (radical concentration decreased up to 31.4 % compared to the control, DMPO alone). Etcarbatone was less effective (up to 98.3 %); efficiency of propcarbatone was better than that of etcarbatone (86.4 %), but worse compared to metcarbatone. The scavenging efficiency of metcarbatone was dependent on the concentration: 0.5 mmol L -1 decreased the radical concentration up to 84.4 % of the radical; when given at concentrations 0.2 or 0.1 mmol L -1 the compound was not effective (not shown). Styrylcarbatone even favoured the radicals' generation up to 106 %.
DNA binding
The UV/VIS spectra of carbatone and propcarbatone are given in Figure 2 , panel A. Other spectra are not shown. All the carbatonides absorbed light in the UV part of spectrum with a maximum at 235 nm and in the visible part of spectrum with a maximum at 380 nm for carbatone and at 355 nm for other carbatonides. In the UV/VIS titration assay carbatone, metcarbatone, etcarbatone, and propcarbatone manifested a slight hypochromic effect when interacting with DNA. the number of cells positive for this apoptotic protein following DM development was normalised by etcarbatone at both doses (P<0.001); metcarbatone did not produce any impact on the number of apoptotic cells. In eye tissues, there was also a three-fold increase (P=0.005) of c-PARP1 positive cells after induction of diabetes; both doses of etcarbatone increased it even more (P<0.001) but metcarbatone showed no effect (Table 3) .
Figure 1 A -EPR spectra of DMPO-OH radicals generated in the Fenton reaction in presence of DMPO. 1 -EPR spectra of DMPO-OH radicals 3 min after mixing the components for the Fenton reaction. 2 -EPR spectra of DMPO-OH radicals 5 min after mixing the components for the Fenton reaction. I 3 and I 5 -intensities of EPR signals used for the quantification of DMPO-OH
Histone H2AX and H2afx gene
Numerical data are presented in Tables 2 and 3 , microphotographs -in Figure 3 . In kidneys, expression of H2AX was observed in proximal and distal canaliculi, in glomeruli, and blood vessel walls (Figure 3 ). The expression of this marker of DNA breakage on gene level did not
Gene and protein expression studies
Styrylcarbatone, metcarbatone, and etcarbatone were chosen for the in vivo studies. These compounds did not produce the hypoglycaemic effect (not shown). The impact of these compounds on the expression of several genes and proteins involved in NO production and DNA repair were tested in the kidneys of normal and diabetic animals. The expression of genes was also monitored in blood samples. Besides kidneys, immunohistochemical studies were performed also on heart, nerve, and eye tissues.
The expression of the Parp1 gene (a marker of DNA repair), cleaved PARP1 protein (a marker of apoptosis), both proteins and genes of histone H2AX (DNA breakage marker) and two NO synthases (iNOS and eNOS) as well as Xdh gene (NO producing enzyme), were monitored. The quantified data of immunohistochemistry and real time PCR for kidneys are given in Tables 2-5 .
Parp1 gene
We could not detect any significant differences in Parp1 gene expression in kidneys of intact rats and animals with STZ diabetes mellitus (Table 2) . However, the administration of styrylcarbatone, etcarbatone, and metcarbatone at both doses caused a highly significant more than two-fold increase (P<0.001) of the Parp1 gene expression in kidneys of intact animals. When administered to diabetic animals, all the three compounds, except etcarbatone at high dose, also caused a strong increase in the gene expression (P<0.01).
In blood cells, diabetes induction was followed by a strong, almost two-fold, increase in Parp1 gene expression (P=0.003). Both doses of etcarbatone attenuated the increase (P<0.001). However, styrylcarbatone and metcarbatone were not effective ( Table 2) .
Cleaved PARP1 (c-PARP1) protein
Development of the STZ-induced diabetes mellitus significantly increased the number of cells positive for c-PARP1 protein, a marker of apoptosis, in kidney tissue (P=0.004). Metcarbatone did not modify the expression of the enzyme in diabetic kidneys, while administration of etcarbatone at both doses decreased the number of cells positive for c-PARP1 in diabetic kidneys (P<0.001), although the compound upregulated the expression of the protein in kidneys of intact animals (P<0.05) ( Table 3) .
In heart tissues, c-PARP1 was detected in cardiomyocytes, in some inflammatory interstitial cells, and around blood vessels (Figure 3) . Development of diabetes mellitus caused a three-fold increase in the cells positive for c-PARP1 protein in myocardium (P=0.025). The number of apoptotic cells was normalised by etcarbatone at both doses (P<0.01) and low dose of metcarbatone (P=0.018). In the sciatic nerve, the c-PARP1 protein was noticed in Schwann's cells and in the inflammatory cells around nerve sheaths (not shown). The three-fold increase (P=0.009) in Ošiņa . Arrow indicates positively stained cells change in the kidneys of animals in any group, however, etcarbatone treatment at both doses up-regulated protein expression in diabetic animals (P<0.01, Table 3 ). In diabetic animals, gene expression increased in blood (P=0.002); etcarbatone at both doses normalised this parameter (P<0.05); effects of styrylcarbatone and metcarbatone were not significant (Table 2 ). In the heart, the expression of histone was observed mostly in the nuclei of cardiomyocytes, to a lesser extent it was also seen in the nuclei of interstitial inflammatory cells and endocardium (not shown). Development of DM increased the number of histone H2AX positive cells in triplicate (P=0.005). Treatment with etcarbatone at both doses enhanced this increase (P<0.001). Metcarbatone at high dose decreased (P=0.038) the expression of H2AX in the nerve of intact rats but no other difference between the groups was observed in nerve and eye tissues (Table 3) .
iNOS (NOS2) enzyme and iNos (Nos2) gene
Numerical data are presented in Tables 4 and 5 . In kidneys, iNOS protein was expressed in glomeruli, canaliculi, stroma, and endothelium of blood vessels (not shown). Induction of diabetes caused a four-fold increase in the number of iNOS-positive cells (P=0.002), etcarbatone at low dose significantly decreased the expression (P=0.001) ( Table 5 ), metcarbatone at low dose caused further upregulation (P<0.001). Strikingly, the effects of the compounds on gene expression level in kidneys were adverse (Table 4) : the development of diabetes produced a less drastic increase in the intensity of gene transcription (P=0.044), etcarbatone at both doses produced an increase in intact animals (P<0.01), and at low dose it increased (P=0.003) the rate of transcription triggered by DM development. A similar effect was produced by metcarbatone at both doses (P<0.001). An even stronger increase in gene transcription was observed in blood cells (P=0.001), however, etcarbatone at both doses (P=0.003) and metcarbatone at low dose (P=0.01) attenuated the effect of DM but styrylcarbatone did not produce any effect. Immunohistochemical analysis of heart tissues revealed the expression of iNOS in cardiomyocytes, inflammatory cells, blood vessel walls, and stroma. The enzyme was detected in pericardium and endocardium but predominant expression was observed in myocardium (not shown). In DM model, the enzyme expression increased four-fold compared to the control group (P=0.003; Table 5 ). A significant decrease in the effect was produced only by etcarbatone at low dose (P=0.007). In the nerve, iNOS Figure 4) ; it increased in diabetic rats (P=0.003). A low dose of etcarbatone increased the expression in control rats (P<0.001), while both doses of etcarbatone decreased it in diabetic animals (P<0.05). Development of DM caused qualitative changes in the distribution of iNOS-positive cells in eye tissues: in the eyes of intact animals the expression was detected mostly in the ciliary body, while in diabetic animals iNOS positive cells were observed also in the retina and vitreous body. The general number of positive cells also increased (Figure 4) . Quantitatively, induction of diabetes increased iNOS expression (P=0.021) but the compounds did not modify the expression significantly (Table 5) .
eNOS (NOS3) enzyme and eNos (Nos3) gene
Data are presented in Tables 4 and 5 . In heart tissues, eNOS expression was observed in the cytoplasm of cardiomyocytes and inflammatory cells and in endothelium (not shown). We could not detect significant differences between control and STZ group, however, etcarbatone treatment at both doses up-regulated the protein expression in the heart of diabetic animals (P<0.001). In kidney tissues, the enzyme was expressed in the cytoplasm of the cells forming proximal and distal canaliculi and in endothelium (not shown). Development of diabetes mellitus decreased the enzyme expression in kidneys compared to controls (P<0.001). The expression was up-regulated by a low dose of metcarbatone (P=0.016) and both doses of etacarbatone (P<0.001, Table 5 ). In nerve cells, eNOS protein expression increased by induction of diabetes (P=0.008). It was normalised by both doses of etcarbatone (P<0.01). In the eyes of intact animals, the expression of eNOS was restricted to the ciliar body; on the contrary, in diabetic animals it was observed not only in the ciliar body, but also in the retina, vitreous body, and inflammatory cells (not shown). Qualitative expansion of the expression was followed also by a numerical increase in eNOS-positive cells (P<0.001).
The expression of eNos gene decreased in the kidneys of diabetic animals (P=0.04, Table 4 ). Both etcarbatone and metcarbatone at high doses increased the expression levels (P=0.009 and P=0.024, respectively). Styrylcarbatone decreased gene expression by high dose in intact animals (P=0.019) and by low dose in diabetic rats (P=0.024).
Xanthine deoxygenase gene (Xdh)
Formerly we have demonstrated that the overall increase in NO production in STZ model of DM was due in part to NOS-independent production of NO by xanthine deoxygenase (10) . Therefore, it was interesting to monitor the expression of this gene. Surprisingly, the increase in gene expression was detected only in the blood of diabetic animals (P=0.006; Table 4 ); styrylcarbatone and etcarbatone decreased it significantly (styrylcarbatone: P=0.02 for low dose; etcarbatone: P=0.003 for low dose, and P=0.001 for high dose). In kidneys, diabetes development did not change the expression of the gene, however, metcarbatone and styrylcarbatone up-regulated its expression in the kidneys of both control (metcarbatone: P=0.04 for low dose, P=0.003 for high dose; styrylcarbatone: P<0.001 for both doses) and diabetic animals (metcarbatone: P<0.001 for both doses, styrylcarbatone: P<0.001 for high dose). Etcarbatone produced similar effects; in the control group, it increased the expression of Xdh gene in the kidneys (P<0.001 for both doses). In diabetic animals, both concentrations of etcarbatone up-regulated gene expression (P=0.001 for low dose and P=0.015 for high dose).
Comet assay
Development of diabetes mellitus increased the level of DNA breakage in white blood cells (P<0.001, Figure 5) . Surprisingly, metcarbatone, etcarbatone, and styrylcarbatone 
Table 4 Effects of carbatonides on expression of iNos and Xdh genes in kidneys and blood of control and diabetic rats
Kidneys, iNos
Kidneys, eNos
Kidneys, Xdh
Blood, iNos
Blood
DISCUSSION
In the present study, we have performed in vitro and in vivo assays of several physicochemical properties and biological activities of carbatonides [disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) derivatives]. Our aim was to evaluate a probable use of these compounds for treatinfg DM complications. It turned out that replacing groups in position 4 could drastically modify the hydroxyl radical scavenging capability of the compounds; metcarbatone was much more effective compared to other compounds. Indeed, former studies indicate that radical-scavenging activity is really determined by position 4; a free carboxylic group in this position is considered to be the most favourable for radical scavenging. Our study shows that methyl group in this position also favours effective scavenging, at least under conditions of the chosen assay. However, radical scavenging activity of 1,4-DHPs strongly depends on the used system (4). Besides position 4, the tested compounds were identical, thus, the considerations that electron donor substituents in positions 2 and 6 promote the quenching of oxidation, as well as stronger electron acceptors in positions 3 and 5 (4) cannot be applied to this study. All five compounds were capable of interacting with DNA, although their affinity to DNA was lower compared to other 1,4-DHPs (10, 12) . The increase in fluorescence of carbatone and propcarbatone in the presence of DNA indicates a probable intercalation mechanism; the quenching of fluorescence by metcarbatone and etcarbatone indicates binding to the outer surface of DNA molecule (18) . Interestingly, styrylacarbatone manifested a higher affinity to DNA, although DNA quenched its fluorescence, ethidium bromide extrusion assay indicates intercalation. The compound might interact with DNA via two mechanisms -intercalation and minor groove binding. Probably, direct interactions of styrylacarbatone, etcarbatone, and metcarbatone with DNA are responsible for DNA damage in white blood cells of the intact animals observed after the administration of these compounds. DNA-damaging effects of antioxidant compounds are a frequently observed phenomenon, for example, antioxidant flavonoids induce oxidative DNA damage serving as temporary carriers of electrons received from transition metal ions that are relayed to oxygen molecules to subsequently generate superoxide and H 2 O 2 (19) . The DNA break reducing effect of metcarbatone in diabetic animals appears to be due to the radical scavenging activity of the compound, the weak scavenger etcarbatone even worsens the situation. This might be the cause of the increase in Parp1 gene expression in intact animals as a consequence of a triggered DNA repair process.
The gene and protein expression studies revealed several effects of these compounds, which appear to be benevolent in condition of diabetes mellitus. Coherent up-regulation of both mRNA and protein of eNOS in the kidneys of diabetic animals triggered by both metcarbatone and etcarbatone appears to be a promising effect. In the myocardium, the decrease in the eNOS protein expression was not pronounced, still etcarbatone up-regulated it in diabetic animals. The uncoupling of the endothelial NO synthase with consequent production of superoxide radical and decrease in NO bioavailability is an important factor in the pathogenesis of complications of DM (20) . To heal the complications, the uncoupling should be pharmacologically reduced (21) but eNOS protein expression should be stimulated; its activity should be increased (22, 23) . Up-regulation of eNOS favours sensitivity to insulin (24). Recent data indicate an important role of the regulation of eNOS expression in many processes, despite its "constitutive" nature (25) . Thus, metcarbatone and etcarbatone appear to produce favourable effects aimed at preventing diabetic nephropathy and cardiomyopathy. However, our results on the eNOS expression in eye tissues contradict the published data, as a decrease in eNOS in diabetic retina was observed by others (26) . It seems that the problem should be studied more in detail. A similar effect was observed in the sciatic nerve, eNOS was up-regulated in diabetic animals, etcarbatone down-regulated its expression. Our data contradict the findings of others (27) indicating a decrease in eNos expression in the sciatic nerve of mice predisposed to development of DM and an increase in expression as a result of the applied therapy. However, our model of DM was different and nerve tissue might have its peculiarities. For example, a simultaneous increase in iNOS and eNOS was observed in the hippocampus of animals subjected to hypoxia (28) . On the contrary, in the paraventricular nucleus of animals with modelled insulin resistance, eNOS was down-regulated; expression of iNOS did not change (29) . Others have also shown an increased as well as decreased expression of eNOS in different tissues of diabetic animals (30) . The observed increase in iNOS protein and iNos gene in the studied tissues of diabetic animals was in good correlation with published data. The increase in iNOS expression coupled to DM was reported for cardiomyocytes (31) , blood vessels (32), retina (26) , sciatic nerve (27) and kidneys (10) . The ability to decrease iNOS expression is considered to be a positive feature in the search for remedies which are aimed to treat diabetes complications (33) . Etcarbatone appears to be prospective from this point of view, as it reduced the expression of iNOS protein in heart, nerve, and kidney tissues, metcarbatone was ineffective. Concerning iNos gene expression, it was drastically upregulated in the kidneys of intact animals by styrylcarbatone and etcarbatone, stronger than in the DM model, and also up-regulated by metcarbatone and etcarbatone in diabetic animals. In blood, the increase in the iNos gene expression was triggered by the development of DM, and etcarbatone and metcarbatone normalised it. Thus, the effects on iNOS protein and gene expression are not coherent. This can be explained by the mechanisms of gene regulation: it is regulated post-transcriptionally to a large extent, maintenance of mRNA stability being very important (34, 35) . The consequences of the observed outburst of mRNA expression could be levelled by post-transcriptional processing. Expression of the Parp1 gene related to DNA repair and induced by DNA breakage resembled to a large extent the pattern of the iNos gene expression, co-ordinate expression of these genes is due to common Nrf-2 pathway of their regulation (36, 37) . Thus, 1,4-DHPs increased the expression of the gene in kidneys of both intact and diabetic animals. 1,4-DHPs per se did not increase gene expression in blood, but etcarbatone attenuated the DM-triggered increase. Interestingly, the effects on Xdh gene expression were similar; the enzyme contributes to a large extent to NOS-independent NO production. Surprisingly, these data are in contradiction with the level of DNA breakagemetcarbatone decreased it in diabetic animals but etcarbatone increased it. The marker of DNA double-strand breaks, the H2AX histone, did not react on DM induction in kidneys neither at gene, nor at protein expression levels. Surprisingly, etcarbatone up-regulated the expression of the protein, indicating the generation of double-strand DNA breaks. Discrepancy between mRNA and protein expression is not surprising, as the antibody detects the phosphorylated form of histone, generated after translation. It is phosphorylated by kinases such as ataxia telangiectasia mutated and ataxia telangiectasia mutated-Rad3-related in the PI3K pathway (38) . However, we did observe an increased expression of the gene in blood cells, coherent with DNA breakage increase; perhaps, this reflects the fact that in lymphocytes the non-phosphorylated form of histone is also translocated to DNA breakage foci (39) triggering an increased transcription of the gene by feedback mechanism. Etcarbatone up-regulated also H2AX histone in myocardium. DNA double-strand breaks are usually associated with final stages of apoptosis; it was interesting to compare data on histone H2AX expression and generation of cleaved PARP1, a marker of apoptosis. In kidneys, DM triggered a sharp increase in the c-PARP1 production; interestingly, etcarbatone treatment produced a strong anti-apoptotic effect. Thus, the DNA double-strand breaks produced by the compound should be repaired. The effects in myocardium were similar, again etcarbatone produced an anti-apoptotic effect, and thus H2AX expression indicates the generation of reparable doublestrand breaks formed prior to apoptosis. Action of etcarbatone in the sciatic nerve is also anti-apoptotic; unfortunately, it is pro-apoptotic in eye tissues.
Taken together, our data indicate that derivatives of disodium-2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) appear to be a prospective compound group for the development of drugs aimed to treat DM complications like diabetic nephropathy, cardiomyopathy, and neuropathy. Etcarbatone appears to be the most prospective due to its ability to down-regulate iNOS, up-regulate eNOS, and prevent apoptosis in kidneys, hearts, and nerves of organisms suffering of hyperglycaemia.
